MELANOTAN I 10MG

Product Points : 80Points

$24.00

Melanotan I (Afamelanotide) is a synthetic melanocortin receptor agonist peptide used in laboratory research to study melanin production, photobiology, and peptide-receptor signaling. It is commonly investigated for its interaction with MC1R receptors in controlled research environments

 

In stock

Add to Wishlist
Add to Wishlist
Secure Payment Methods

Description

Melanotan I (Afamelanotide) Peptide Overview

Melanotan I, also known as Afamelanotide, is a synthetic analog of alpha-melanocyte–stimulating hormone (α-MSH). It is widely used in research for its ability to bind to melanocortin receptors, particularly MC1R, making it valuable in studies of melanin synthesis, photoprotection pathways, and receptor-mediated signaling.


Research Applications

Melanotan I is utilized in laboratory and analytical studies involving:

  • Melanin production and pigmentation research
  • Melanocortin receptor (MC1R) signaling studies
  • Photobiology and UV-response research
  • Peptide-receptor binding analysis
  • Molecular and cellular signaling investigations

Mechanism of Action

Melanotan I binds to melanocortin receptors, especially MC1R, which are involved in regulating melanin synthesis pathways. This interaction is studied to better understand:

  • Cellular pigmentation signaling
  • Receptor activation and downstream pathways
  • Molecular responses to environmental stimuli

Handling & Storage (Research Use)

  • Store lyophilized peptide at -20°C or colder
  • After reconstitution, store at 2–8°C
  • Avoid repeated freeze–thaw cycles
  • Protect from light and contamination

Quality & Research Use

Each batch of Melanotan I is prepared to meet strict laboratory standards, supporting consistency, purity, and reproducibility in research environments.

⚠️ For research and educational purposes only. Not for human or veterinary use.

Reviews

There are no reviews yet

Be the first to review “MELANOTAN I 10MG”
Review now to get coupon!

Your email address will not be published. Required fields are marked *